Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro (Q42435270)

31 October 2017

Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro (English)

1 reference

31 October 2017

1 reference

K C Grobaski

1

1 reference

31 October 2017

H Ping

2

1 reference

31 October 2017

H M daSilva

3

1 reference

31 October 2017

N G Bowery

4

1 reference

31 October 2017

S T Connelly

5

1 reference

31 October 2017

P D Shepard

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

British Journal of Pharmacology

31 October 2017

1 reference

31 October 2017

120

1 reference

31 October 2017

4

1 reference

31 October 2017

575-580

1 reference

Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes

31 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

Solubilization and characterization of GABAB receptor binding sites from porcine brain synaptic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

N-methyl-D-aspartate transmission modulates GABAB-mediated inhibition of rat hippocampal pyramidal neurons in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Clinical Pharmacokinetics of Hypnotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Regulation of spontaneous activity and oscillatory spike firing in rat midbrain dopamine neurons recorded in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Modulation by different GABAB receptor types of voltage-activated calcium currents in rat thalamocortical neurones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Pharmacological characterization of pre- and postsynaptic GABAB receptors in the deep nuclei of rat cerebellar slices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

CGP 35348: a centrally active blocker of GABAB receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Effects of the enantiomers of (+/-)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700938

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0700938

1 reference

31 October 2017

1 reference

31 October 2017

PubMed publication ID

9051293

1 reference